[go: up one dir, main page]

DK1432738T3 - Carbonhydratbindingsdomæne indeholdende fusionsproteiner til afgivelse af terapeutiske og andre midler samt sammensætninger indeholdende fusionsproteinerne - Google Patents

Carbonhydratbindingsdomæne indeholdende fusionsproteiner til afgivelse af terapeutiske og andre midler samt sammensætninger indeholdende fusionsproteinerne

Info

Publication number
DK1432738T3
DK1432738T3 DK02800565T DK02800565T DK1432738T3 DK 1432738 T3 DK1432738 T3 DK 1432738T3 DK 02800565 T DK02800565 T DK 02800565T DK 02800565 T DK02800565 T DK 02800565T DK 1432738 T3 DK1432738 T3 DK 1432738T3
Authority
DK
Denmark
Prior art keywords
fusion proteins
binding domain
therapeutic
delivery
agents
Prior art date
Application number
DK02800565T
Other languages
Danish (da)
English (en)
Inventor
Neil James Parry
Stephen George Barnwell
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Application granted granted Critical
Publication of DK1432738T3 publication Critical patent/DK1432738T3/da

Links

Classifications

    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H17/00—Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
    • D21H17/20—Macromolecular organic compounds
    • D21H17/21—Macromolecular organic compounds of natural origin; Derivatives thereof
    • D21H17/22—Proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/24—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients to enhance the sticking of the active ingredients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/258—Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622—Microcapsules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK02800565T 2001-10-03 2002-09-19 Carbonhydratbindingsdomæne indeholdende fusionsproteiner til afgivelse af terapeutiske og andre midler samt sammensætninger indeholdende fusionsproteinerne DK1432738T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01308467 2001-10-03
PCT/EP2002/010523 WO2003031477A1 (fr) 2001-10-03 2002-09-19 Proteines de fusion contenant un domaine de liaison aux hydrates de carbone pour la liberation d'agents therapeutiques et autres agents, et compositions les renfermant

Publications (1)

Publication Number Publication Date
DK1432738T3 true DK1432738T3 (da) 2009-05-25

Family

ID=8182323

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02800565T DK1432738T3 (da) 2001-10-03 2002-09-19 Carbonhydratbindingsdomæne indeholdende fusionsproteiner til afgivelse af terapeutiske og andre midler samt sammensætninger indeholdende fusionsproteinerne

Country Status (10)

Country Link
US (1) US20050107256A1 (fr)
EP (1) EP1432738B1 (fr)
JP (1) JP4537060B2 (fr)
AT (1) ATE424418T1 (fr)
AU (1) AU2002333865B2 (fr)
CA (1) CA2458392A1 (fr)
DE (1) DE60231417D1 (fr)
DK (1) DK1432738T3 (fr)
IL (2) IL160641A0 (fr)
WO (1) WO2003031477A1 (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1862539T3 (da) 2003-05-29 2012-05-14 Danisco Us Inc Nye trichodermagener
US7807141B2 (en) 2003-09-08 2010-10-05 E.I. Du Pont De Nemours And Company Peptide-based oral care surface reagents for personal care
US7285264B2 (en) 2003-09-08 2007-10-23 E.I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
US7220405B2 (en) 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
US7585495B2 (en) 2003-09-08 2009-09-08 E. I. Du Pont De Nemours And Company Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom
US7802572B2 (en) * 2004-09-20 2010-09-28 Sutter West Bay Hospitals Face mask
US7736633B2 (en) 2005-09-28 2010-06-15 E.I. Du Pont De Nemours And Company Method for enhancing effects of colorants and conditioners
US7858581B2 (en) 2005-12-15 2010-12-28 E. I. Du Pont De Nemours And Company PMMA binding peptides and methods of use
US7700716B2 (en) 2005-12-15 2010-04-20 E. I. Du Pont De Nemours And Company Polytetrafluoroethylene binding peptides and methods of use
US7928076B2 (en) 2005-12-15 2011-04-19 E. I. Du Pont De Nemours And Company Polypropylene binding peptides and methods of use
US7709601B2 (en) 2005-12-15 2010-05-04 E. I. Du Pont De Nemours And Company Nylon binding peptides and methods of use
US7906617B2 (en) 2005-12-15 2011-03-15 E. I. Du Pont De Nemours And Company Polyethylene binding peptides and methods of use
US7632919B2 (en) 2005-12-15 2009-12-15 E.I. Du Pont De Nemours And Company Polystyrene binding peptides and methods of use
PT2476435T (pt) 2006-08-11 2018-03-05 Life Sciences Res Partners Vzw Péptidos imunogénicos e a sua utilização em distúrbios imunitários
CA2715611C (fr) 2008-02-14 2018-03-13 Life Sciences Research Partners Vzw Immunotherapie ciblant des agents pathogenes intracellulaires
AU2009214041A1 (en) 2008-02-14 2009-08-20 Katholieke Universiteit Leuven CD4+ T-cells with cytolytic properties
US8999346B2 (en) * 2008-02-14 2015-04-07 Life Sciences Research Partners Vzw Immunogenic control of tumours and tumour cells
WO2009101204A2 (fr) 2008-02-14 2009-08-20 Life Sciences Research Partners Vzw Élimination de réponses immunitaires dirigées contre des vecteurs viraux
CA2751694C (fr) 2009-02-06 2018-04-17 Cornell University Souches de trichoderma qui induisent une resistance a des maladies vegetales et/ou augmentent la croissance des plantes
US8481678B2 (en) 2009-03-30 2013-07-09 E I Du Pont De Nemours And Company Peptide-based tooth whitening reagents
WO2011124612A1 (fr) 2010-04-06 2011-10-13 Vib Vzw Distribution spécifique de produits agrochimiques
HUE036251T2 (hu) * 2010-08-26 2018-06-28 Agrosavfe N V Kitinféle poliszacharid antigént kötõ fehérjék
RU2615460C2 (ru) 2010-11-25 2017-04-04 Имнейт Сарл Иммуногенные пептиды для применения в профилактике и/или лечении инфекционных заболеваний, аутоиммунных заболеваний, иммунных ответов на аллогенные факторы, аллергических заболеваний, опухолей, отторжения трансплантата и иммунных ответов против вирусных векторов. используемых для генной терапии или генной вакцинации
JP2012246227A (ja) * 2011-05-25 2012-12-13 Mie Univ 土壌病害防除剤、及びこの防除剤を用いた土壌病害防除方法
CA2851040A1 (fr) 2011-10-06 2013-04-11 Agrosavfe N.V. Fabrication de microcapsules a ciblage specifique
GB201201511D0 (en) 2012-01-30 2012-03-14 Univ Leuven Kath Modified epitopes for boosting CD4+ T-cell responses
GB201309469D0 (en) 2013-05-28 2013-07-10 Imcyse Sa Detection of CD4+ T lymphocytes
CA2955900C (fr) 2014-04-17 2022-10-18 Basf Se Combinaison de nouveaux inhibiteurs de nitrification et de biopesticides ainsi que combinaison de triamides d'acide (thio)phosphorique de biopesticides
WO2015081349A2 (fr) 2014-04-17 2015-06-04 Basf Se Combinaison de nouveaux inhibiteurs de nitrification et d'herbicides ainsi qu'une combinaison de triamides d'acide (thio)phosphorique et d'herbicides
GB201418433D0 (en) 2014-10-17 2014-12-03 Imcyse Sa Novel immunogenic peptides
JP6743032B2 (ja) 2015-02-06 2020-08-19 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 硝化抑制剤としてのピラゾール化合物
AU2016260805A1 (en) 2015-05-12 2017-11-23 Basf Se Thioether compounds as nitrification inhibitors
US10729791B2 (en) 2015-05-18 2020-08-04 Imcyse Sa Animal models for evaluating pharmaceutical compounds
EP3352782B1 (fr) 2015-09-25 2021-03-31 ImCyse SA Composés et procédés améliorés permettant de supprimer des réponses immunitaires à des agents thérapeutiques
KR20240015731A (ko) 2016-04-19 2024-02-05 임시스 에스에이 신규 면역원성 CD1d 결합 펩티드
MX2018014176A (es) 2016-05-18 2019-02-28 Basf Se Capsulas que comprenden bencilpropargileteres para usar como inhibidores de la nitrificacion.
CA3073449A1 (fr) 2017-09-25 2019-03-28 Agrospheres, Inc. Compositions et procedes de production et d'administration evolutive de produits biologiques
CA3087313A1 (fr) 2018-01-09 2019-08-01 Basf Se Composes silylethynyle hetaryle a utiliser en tant qu'inhibiteurs de nitrification
EP3758491A1 (fr) 2018-02-28 2021-01-06 Basf Se Utilisation d'éthers de pyrazole propargyle comme inhibiteurs de nitrification
US11578012B2 (en) 2018-02-28 2023-02-14 Basf Se Use of N-functionalized alkoxy pyrazole compounds as nitrification inhibitors
EP3758492A1 (fr) 2018-02-28 2021-01-06 Basf Se Utilisation d'alkoxypyrazoles comme inhibiteurs de nitrification
WO2020002472A1 (fr) 2018-06-28 2020-01-02 Basf Se Utilisation d'alkynylthiophènes en tant qu'inhibiteurs de nitrification
US12122728B2 (en) 2018-07-23 2024-10-22 Basf Se Use of substituted 2-thiazolines as nitrification inhibitors
EP3826982B1 (fr) 2018-07-23 2023-11-01 Basf Se Utilisation d'un composé de thiazolidine substitué comme inhibiteur de nitrification
EP4288398A1 (fr) 2021-02-02 2023-12-13 Basf Se Action synergique de dcd et d'alcoxypyrazoles en tant qu'inhibiteurs de nitrification
EP4049749A1 (fr) * 2021-02-25 2022-08-31 Basf Se Nouveaux microcapsules contenant des substances actives
CN117440946A (zh) 2021-05-21 2024-01-23 巴斯夫欧洲公司 N-官能化的烷氧基吡唑化合物作为硝化抑制剂的用途
CN117355504A (zh) 2021-05-21 2024-01-05 巴斯夫欧洲公司 乙炔基吡啶化合物作为硝化抑制剂的用途
WO2022253998A1 (fr) * 2021-06-04 2022-12-08 University Of Copenhagen Peptides ayant des propriétés de liaison à la mucine
WO2022268810A1 (fr) 2021-06-21 2022-12-29 Basf Se Réseaux organométalliques à blocs de construction à base de pyrazole
US20250051266A1 (en) 2021-12-23 2025-02-13 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Novel GLV-Phenolamide: Biosynthesis and Function in Protecting Plants from Herbivore Attack
WO2023203066A1 (fr) 2022-04-21 2023-10-26 Basf Se Action synergique en tant qu'inhibiteurs de nitrification d'oligomères de dicyandiamide (dcd) avec l'alcoxypyrazole et ses oligomères
EP4601745A1 (fr) * 2022-10-14 2025-08-20 Bactolife A/S Protéine de fusion sdab-cbm liée à un polymère de polysaccharide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137819A (en) * 1988-07-08 1992-08-11 University Of British Columbia Cellulose binding fusion proteins for immobilization and purification of polypeptides
US5496934A (en) * 1993-04-14 1996-03-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nucleic acids encoding a cellulose binding domain
BR9813358A (pt) * 1998-01-16 2000-10-03 Unilever Nv Conjugado de polissacarìdeo, produto, e, processo de ligação de marcação de uma entidade à celulose
AU7275598A (en) * 1998-05-01 1999-11-23 Procter & Gamble Company, The Fabric care compositions comprising cellulose binding domains
WO1999057155A1 (fr) * 1998-05-01 1999-11-11 The Procter & Gamble Company Detergent de lavage et/ou compositions respectant les tissus comprenant une proteine antimicrobienne modifiee
AU3009401A (en) * 1999-12-22 2001-07-03 Howell, Steven Method of treating fabrics
EP1240298B1 (fr) * 1999-12-22 2007-10-31 Unilever N.V. Compositions detergentes comprenant des agents ameliorants

Also Published As

Publication number Publication date
ATE424418T1 (de) 2009-03-15
JP2005520789A (ja) 2005-07-14
EP1432738A1 (fr) 2004-06-30
US20050107256A1 (en) 2005-05-19
EP1432738B1 (fr) 2009-03-04
DE60231417D1 (de) 2009-04-16
IL160641A0 (en) 2004-07-25
CA2458392A1 (fr) 2003-04-17
IL160641A (en) 2010-11-30
JP4537060B2 (ja) 2010-09-01
AU2002333865B2 (en) 2006-02-23
WO2003031477A1 (fr) 2003-04-17

Similar Documents

Publication Publication Date Title
DK1432738T3 (da) Carbonhydratbindingsdomæne indeholdende fusionsproteiner til afgivelse af terapeutiske og andre midler samt sammensætninger indeholdende fusionsproteinerne
DE60224284D1 (de) Stabile formulierung von modifiziertem glp-1
BR9812634A (pt) April - uma proteìna com efeitos de crescimento
BR0309546A (pt) Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
BR0109107A (pt) Usos terapêuticos de mediadores ppar
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
BR0311313A (pt) Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase
EE05477B1 (et) Nahale aplitseeritavad vedelpreparaadid parasiitputukate t?rjumiseks loomadel
DZ3191A1 (fr) Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
BR0113112A (pt) Anticorpos, de integrina antidual, composições, métodos e usos
ATE345133T1 (de) Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin
HRP20020880B1 (en) New pharmaceutical composition
FR2811552B1 (fr) Composition notamment cosmetique ou pharmaceutique se presentant sous forme solide
NO20042694L (no) 17 alfa-alkyl-17 beta-oksy-ostratriener og mellomprodukter for fremstilling av disse, anvendelse av 17 alfa-alkyl-17 beta-oksy-ostratrienene til fremstilling av legemidler samt farmasoytiske preparater
ATE286057T1 (de) Pharmazeutische zubereitungen enthaltend clavulansäure
DK0991654T3 (da) Hidtil ukendte derivater af 2-(iminomethyl)aminophenyl, deres fremstilling, deres anvendelse til medikamenter og farmaceutiske præparater indeholdende samme
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
BRPI0414215A (pt) tienopirazóis
EP2292255A3 (fr) Proteines thérapeutiques stables
BR0109846A (pt) Uso de uma composição que compreende um anticorpo ou um fragmento de ligação de antìgeno deste, e conjunto
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
ATE139226T1 (de) Aminosulfonylharnstoff-acat-inhibitoren
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
NO20054440L (no) Flytende formuleringer av tumornekrosefaktorbindende proteiner